Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Johnson & Johnson - Driving EGFR-mutant NSCLC care forward

Welcome and introductions

Date

15 Sep 2024

Session

Johnson & Johnson - Driving EGFR-mutant NSCLC care forward

Topics

Cancer Biology;  Pathology/Molecular Biology;  Targeted Therapy;  Cancer Epidemiology

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Noemi Reguart Aransay

Authors

N. Reguart Aransay

Author affiliations

  • Dept. Medical Oncology, Hospital Clinic y Provincial de Barcelona, 08036 - Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion

Presenter: Noemi Reguart Aransay, Antonio Passaro, Sanjay Popat, Alexander Spira, Enriqueta Felip

Session: Johnson & Johnson - Driving EGFR-mutant NSCLC care forward

Resources:

Webcast

Discussion

Presenter: Noemi Reguart Aransay, Antonio Passaro, Sanjay Popat, Alexander Spira, Enriqueta Felip

Session: Johnson & Johnson - Driving EGFR-mutant NSCLC care forward

Resources:

Webcast

Closing remarks

Presenter: Antonio Passaro

Session: Johnson & Johnson - Driving EGFR-mutant NSCLC care forward

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.